Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: If you're a contrarian....

What price would you therefore place on NXP and do they owe for past infringement?

NXP revenue for the Q ending Sept 30, 2007 was $1.77 Bil (EUR 1,211 million)

http://www.nxp.com/acrobat_download/other/investor/3q_2007_report.pdf

Share
New Message
Please login to post a reply